Comparing the Nab-PHP and TCbHP in Neoadjuvant Therapy for Operable Breast Cancer With HER2 Positive, A Multicenter, Randomized, Phase III Clinical Trial

Condition:   Breast Cancer,Her2 Positive Interventions:   Drug: Albumin binding paclitaxel+ trastuzumab+ patuzumab;   Drug: Docetaxel+ carboplatin+ trastuzumab + patuzumab Sponsor:   Henan Cancer Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials